CLINICAL STUDY: METABOLIC INHIBITION OF VLDL AND ASSOCIATED HCV PRODUCTION BY A SINGLE ORAL DOSE OF NARINGENIN NANOCOMPLEXA. Y. Kim, E. Levant,L. L. Reyor,R. T. Chung,Y. NahmiasJournal of Hepatology(2012)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要